Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection

Current HIV Research

Volumn 2, Issue 2, 2004, Pages 185-191

  Morris, Kevin V ^a   Rossi, John J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Conditionally replicating vectors; HIV 1 gene therapy; Ribozymes; SiRNA; Vector mobilization

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; COMPLEMENTARY RNA; LENTIVIRUS VECTOR; REV PROTEIN; RIBOZYME; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; CELL DIVISION; DRUG TARGETING; FEASIBILITY STUDY; FELINE IMMUNODEFICIENCY VIRUS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; REVIEW; SIDE EFFECT; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INACTIVATION; VIRUS REPLICATION; WILD TYPE;

BASE SEQUENCE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMANS; LENTIVIRUS; MOLECULAR SEQUENCE DATA; RNA, ANTISENSE; RNA, CATALYTIC; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 3042841635     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162043484906     Document Type: Review

References (83)

1. Joshi S, Shi-Fa D, Liam SE. (1997). Nucleic Acids Research. 25: 3199-3204.
2. Coburn GA, Cullen BR. (2002). Journal of Virology. 76: 9225-9231.
3. Elbashir SM, Lendeckel W, Tuschl T. (2001). Genes and Development. 15: 188-200.
4. Jacque J, Triques K, Stevenson M. (2002). Nature. 418: 1-4.
5. Lee NS, Dohjima T, Bauer G, Li H, Li M, Ehsani A, Salvaterra P, Rossi J. (2002). Nature Biotechnology. 20: 500-505.
6. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee S, Collman RG, Leiberman J, Shankar P, Sharp PA. (2002). Nature Medicine. 8: 681-686.
7. Idemyor V. (2003). Pharmacotherapy. March 23(3): 384-387.
8. Ho DD, Huang Y, (2002). Cell. 110: 135-138.
9. D'Aquila RT, Schapiro JM, Brun-Vezinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. (2003). Topics in HIV Medicine. 11: 92-96.
10. Maggiolo F, Ripamonti D, Suter F. (2003). HIV Clinical Trials. 4: 193-201.
11. Guerrier-Takada C, Gardiner K, Marsch T, Pace N, Altman S. (1983). Cell. 35: 849-857.
12. Kruger K, Grabowski J, Zaug AJ, Sands J, Gottschling DE, Cech TR. (1982). Cell. 31: 147-157.
13. Marschall J, Thomson B, Eckstein F. (1994). Cellular and Molecular Neurobiology. 14: 523-538.
14. Cech TR. (1990). Annual Review in Biochemistry. 59: 543-568.
15. James HA, Gibson I. (1998). Blood. 91: 371-382.
16. Amarzguioui M, Prydz H. (1998). Cellular and Molecular Life Sciences. 54: 1175-1202.
17. Zhou C, Bahner IC, Larson G, Zaia JA, Rossi JJ, Kohn DB. (1994). Gene, 149: 33-39.
18. Yamada O, Yu M, Yee JK, Kraus G, Looney D, Wong-Staal F. (1994). Gene Therapy. 1: 38.
19. Akhtar S, James H, Gibson I. (1995). Nature Medicine. 1: 300-302.
20. Macpherson JL, Ely JA, Sun L. (1999). Frontiers in Bioscience. 4: 497-505.
21. Rossi JJ. (2000). Advanced Drug Delivery Reviews. 44: 71-78.
22. Leavitt MC, Yu M, Yamada O, Kraus G, Looney D, Poeschla E, Wong-Staal F, (1994). Human gene Therapy. 5: 1115-1120.
23. Dropulic B, Lin NH, Martin MA, Jeang K. (1992). Journal of Virology. 66: 1432-1441.
24. Sioud M, Drlica K. (1991). Proceedings of National Academy of Sciences. 88: 7303-7307.
25. Sun LQ, Wang L, Gerlach WL, Symonds G. (1995). Nucleic Acids Research. 23: 2909-2913.
26. Michienzi A, Prislei S, Bozzoni I. (1996). Proceedings of the National Academy of Sciences. 93: 7219-7224.
27. Nishikura K. (2001). Cell. 107: 415-418.
28. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Nature. 391: 806-811.
29. Sui G, Soohoo C, Affar E, Gay F, Shi Y, Forrester WC, Shi Y. (2002). PNAS. 99: 5515-5520.
30. Wesley SV, Helliwell CA, Smith NA, Wang M, Rouse MT, Liu Q, Gooding S, Singh S, Abbott D, Stoutjesdijk A, Robinson S, Gleave A, Green AG, Waterhouse M. (2001). The Plant Journal. 27: 581-590.
31. Paddison J, Caudy AA, Hannon GJ. (2002). Proceeding of the National Academy of Sciences. 99: 1443-1448.
32. Brummelkamp TR, Agami BR. (2002). Science. 296: 550-553.
33. Zeng Y, Cullen BR. (2002). RNA. July 8: 855-860.
34. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. (2002). Cell. 110: 563-74.
35. Sumimoto H, Miyagishi M, Miyoshi H, Taira K, Kawakami Y. (2003). Molecular Therapy. 7: S34.
36. Hamada M, Ohtsuka T, Kawaida R, Koizumi M, Morita K, Furukawa H, Imanishi T, Miyagishi M, Taira K. (2002). Antisense Nucleic Acid Drug Dev. 12: 301-9.
37. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. (2003). Journal of Virology. 77: 11531-11535.
38. Holen T, Amarzguioui M, Wiger MT, Babaie E, Prydz H. (2002). Nucleic Acids Research. 30: 1757-1766.
39. Tuschl T. (2002). Nature Biotechnology. 20: 446-448.
40. Song, E, Lee S, Dykxhoorn DM, Novina C, Zhang D, Crawford K, Cerny J, Sharp A, Leiberman J, Manjunath N, Shankar P. (2003). Journal of Virology. 77: 7174-7181.
41. Scherr M, Rossi JJ. (1998). Nucleic Acids Research. 26: 5079-5085.
42. Richman DD, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, et al. (1994). Journal of Virology. 68: 1660-1666.
43. Surabhi RM, Gaynor RB. (2002). Journal of Virology. 76: 12963-73.
44. Qin X, An D, Chen IS, Baltimore D. (2002). Proceeding of the National Academy of Sciences. 100: 183-188.
45. Duzgunes N, Simoes S, Konopka K, Rossi JJ, Pedroso de Lima MC. (2001). Expert Opinion in Biological Therapy. 6: 949-970.
46. Buchschacher GL, Wong-Staal F. (2000). Blood. 95: 2499-2504.
47. Swindle CS, Klug CA. (2002). Journal of Hematotherapy Stem Cell Research. 3: 449-456.
48. Wu X, Li Y, Crise B, Burgess SM. (2003). Science. 300: 1749-1751.
49. Greber UF, Fassati A. (2003). Traffic. 4: 136-143.
50. Gervaix A, Schwarz L, Law AD, Ho D, Looney D, Wong-Staal F. (1997). Human Gene Therapy. 8: 2229-2238.
51. Yam Y, Li S, Wu JU, Hu J, Zaia JA, Yee J. (2002). Molecular Therapy. 5: 479-484.
52. Price MA, Case SS, Carbonaro DA, Yu XJ, Petersen D, Sabo KM, Curran MA, Engel BC, Margarian H, Abkowitz JL, Nolan GP, Kohn DB. (2002). Molecular Therapy. 6: 645-652.
53. Poeschla E, Corbeau J, Wong-Staal F. (1996). Proceedings of the National Academy of Sciences. 93: 11395-11399.
54. Quinonez R, Sutton RE. (2002). DNA Cell Biology. 12: 937-951.
55. Horn A, Morris JC, Bukovsky AA, Andrews RG, Naldini L, Kiem HP. (2002). Gene Therapy, 2002. 9: 1464-1471.
56. Browning MT, Schmidt RD, Lew KA, Rizvi TA. (2001). Journal of Virology. 75: 5129-5140.
57. White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JR, Planelles V. (1999). Journal of Virology. 73: 2832-2840.
58. Goujon C, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix J, Cimarelli A. (2003). Journal of Virology. 787: 9295-9304.
59. Kobinger G, Weiner DJ, Yu Q, Wilson JM. (2001). Nature Biotechnology. 19: 225-230.
60. Sandrin V, Russell SJ, Cosset FL. (2003). Current Topics in Microbiology and Immunology. 281: 137-178.
61. Boerger AL, Snitkovsky S, Young JA. (1999). Proceedings of the National Academy of Sciences. 96: 9867-9872.
62. Ho AD, Li X, Lane TA, Yu M, Law F, Wong-Staal F. (1995). Stem Cells. December 13(Suppl. 3): 100-105.
63. Bauer GV, Kearns K, Bahner I, Wen SF, Zaia JA, Kohn DB. (1997). Blood. 89: 2259-2267.
64. Dropulic B, Hermankova M, Pitha M. (1996). Proceedings of National Academy of Sciences. 93: 11103-11108.
65. Evans JT, Garcia JV. (2000). Human Gene Therapy. 11: 2331-2339.
66. Dropulic BM, Pitha M. (1996). Proceedings of the National Academy of Sciences. 93: 11103-11108.
67. Bukovsky AA, Song J, Naldini L. (1999). Journal of Virology. 73: 7987-7992.
68. Corbeau J, Wong-Staal F. (1998). Virology. 243: 268-274.
69. Klimatcheva E, Planelles V, Day SL, Fulreader F, Renda MJ, Rosenblatt J. (2001). Molecular Therapy. 3: 928-939.
70. Mautino MR, Morgan RA. (2002). AIDS patient care and STDs. 16: 11-26.
71. Mautino MR, Morgan RA. (2002). Gene Therapy. 9: 421-431.
72. Mautino MR, Morgan RA. (2000). Human Gene Therapy. 11: 2025-2037.
73. Mautino MR, Ramsey WJ, Reiser J, Morgan RA. (2000). Human Gene Therapy. 11: 895-908.
74. Mautino MR, Keiser N, Morgan RA. (2001). Journal of Virology. 75: 3590-3599.
75. Giordano V, Jin D, Rekosh D, Jeang K. (2000). Virology. 267: 174-184.
76. Weinberger LS, Schaffer DV, Arkin A. (2003). Journal of Virology. 77: 10028-10036.
77. Gazzard B. (1999). International Journal of Clinical Practice Supplement. 103: 145-148.
78. Shafer RW, Vuitton DA. (1999). Biomedical Parmacotherapy. 53: 73-86.
79. Cullinan K. (2002). Bulliten World Health Organ. 80: 761-2.
80. Mautino MR. (2002). Current Gene Therapy. 2: 23-43.
81. Turner E, Chao L. (1999). Nature. 398: 441-443.
82. Turner E, (2003). ASM News. 69: 289-295.
83. Lama J. (2003). Current HIV Research. 1: 167-184.